Comprehensive supplier audit checklist for medical device manufacturers — covering supplier risk classification, qualification, audit agenda, purchasing controls per ISO 13485 Clause 7.4 and FDA QMSR, quality agreements, outsourced sterilization/testing/software, CAPA follow-up, and evidence records.
Why Supplier Audits Are a 2026 Regulatory Priority
FDA's Quality Management System Regulation (QMSR), effective February 2, 2026, incorporates ISO 13485:2016 by reference. A critical change: FDA inspectors can now review internal audit records and supplier audit records — areas previously off-limits under the former Quality System Regulation (QSR). This means your supplier audit documentation may be examined during your next FDA inspection.
ISO 13485 Clause 7.4 requires manufacturers to establish criteria for supplier selection, evaluation, monitoring, and re-evaluation based on the risk the purchased product poses to the medical device. The level of control must be proportionate to that risk.
This checklist provides a structured, audit-ready framework for supplier qualification, on-site auditing, ongoing monitoring, and evidence documentation. It is designed for medical device manufacturers preparing for both ISO 13485 certification and FDA QMSR compliance.
Supplier Risk Classification
Before auditing, classify each supplier to determine the appropriate level of oversight.
Risk Tier Classification Matrix
Tier
Classification
Definition
Examples
Audit Frequency
Quality Agreement
On-Site Audit
A
Critical
Directly affects device safety and effectiveness
Contract sterilization, implant component manufacturers, contract manufacturers, critical software developers
Annual + for-cause
Required
Required
B
Major
Influences product quality but not directly patient safety
Raw material suppliers, packaging suppliers, non-critical component manufacturers
Biennial or annual
Recommended
Recommended
C
Minor
Minimal impact on product quality
Office supplies, non-critical consumables, general IT services
As needed
Not required
Not required
D
Indirect
No direct product impact
Facility maintenance, catering
Periodic review
Not required
Not required
Risk Scoring for Classification
Factor
High (3)
Medium (2)
Low (1)
Impact on device safety
Direct patient contact or life-supporting function
Affects device performance
Minimal or no effect
Complexity of supplied product/service
Custom-designed, requires validated process
Standard product with custom specifications
Off-the-shelf commodity
Regulatory sensitivity
Sterilization, biocompatibility testing, software in device
General testing, calibration services
Standard industrial services
Substitutability
Sole source, long qualification lead time
Limited alternatives available
Multiple equivalent sources
Supplier QMS maturity
No ISO 13485 or QMSR compliance history
ISO 9001 or partial medical device experience
ISO 13485 certified, proven track record
Scoring: 13-15 = Tier A (Critical) | 9-12 = Tier B (Major) | 5-8 = Tier C (Minor) | <5 = Tier D (Indirect)
Supplier Qualification Checklist
Use this checklist during the initial evaluation of a new supplier.
Pre-Qualification Desktop Review
#
Item
Reference
Evidence Required
Pass/Fail
1
ISO 13485:2016 certificate (or equivalent QMS certification)
ISO 13485 7.4.1
Current certificate, scope covers supplied product, accredited CB
☐
2
FDA registration and device listing (if US supplier)
21 CFR 807
Registration confirmation
☐
3
Regulatory compliance history (warning letters, consent decrees, import alerts)
Risk assessment
FDA database search, EUDAMED vigilance check
☐
4
Financial stability assessment
Risk assessment
D&B report or equivalent
☐
5
Business continuity and disaster recovery plan
ISO 13485 7.4.1, risk management
Documented BCP
☐
6
Insurance and liability coverage
Risk assessment
Certificate of insurance
☐
7
Prior audit reports (if sub-tier audits available)
ISO 13485 7.4.1
Third-party or customer audit results
☐
8
MDSAP certificate (if applicable)
MDSAP requirements
Current MDSAP certificate
☐
9
Material/product specifications review
ISO 13485 7.4.2
Specifications match requirements
☐
10
Change notification agreement
ISO 13485 7.4.2
Written agreement to notify of changes
☐
Quality Agreement Requirements (Tier A and B Suppliers)
#
Quality Agreement Clause
Content
Reference
1
Scope of agreement
Products/services covered; responsibility allocation
ISO 13485 7.4.2
2
Specifications and acceptance criteria
Detailed product specifications, testing requirements
ISO 13485 7.4.2
3
Change control
Notification requirements and timelines for product/process changes
ISO 13485 7.4.2, 7.3.9
4
Right to audit
Customer's right to conduct on-site audits, with notice period
ISO 13485 7.4.1
5
Record retention
Minimum retention period (minimum device lifetime + regulatory requirement)
ISO 13485 4.2.5
6
Complaint and adverse event notification
Timeline for notifying customer of quality events
ISO 13485 8.2.2
7
Corrective action responsibilities
CAPA process and escalation procedures
ISO 13485 8.5.2
8
Traceability requirements
Lot/batch traceability, UDI compatibility
ISO 13485 7.5.9
9
Sub-tier supplier control
Requirements for supplier's own supplier management
ISO 13485 7.4.1
10
Intellectual property and confidentiality
IP protection, data handling
Contract law
11
Termination and transition provisions
Exit strategy, data return, transition support
ISO 13485 7.4.1
12
Regulatory inspection support
Obligation to support FDA/NB inspections related to supplied product
QMSR, ISO 13485
Recommended Reading
Pre-Filled Syringes and Auto-Injectors: Drug-Device Combination Product Regulatory Strategy
Regulatory Standards & Testing 2026-04-30 · 14 min read
On-Site Audit Agenda Checklist
Audit Preparation
#
Preparation Item
Responsible
Completed
1
Confirm audit scope and objectives with supplier
Lead Auditor
☐
2
Send audit plan/agenda to supplier minimum 2 weeks before
Lead Auditor
☐
3
Review previous audit findings and CAPA status
Audit Team
☐
4
Review supplier's QMS documentation (quality manual, key SOPs)
Audit Team
☐
5
Prepare audit checklist customized to supplied product/service
Lead Auditor
☐
6
Confirm audit team composition (minimum 1 qualified lead auditor)
QA Manager
☐
7
Ensure auditor independence (no direct responsibility for the process being audited)
QA Manager
☐
Day 1: Opening and Quality Management System
Time
Agenda Item
Checklist Focus
ISO 13485 Reference
QMSR Reference
09:00
Opening meeting
Introductions, scope confirmation, facility tour request
—
—
09:30
Quality management system overview
Quality manual, quality policy, organizational structure, management responsibility
4.1, 5.1-5.6
§820.10 (incorporating ISO 13485 by reference)
10:30
Document control
Document approval, distribution, revision control, external document control
4.2.3, 4.2.4
§820.10
11:30
Record control
Record creation, storage, retrieval, retention, protection
4.2.5
§820.10
13:00
Risk management
ISO 14971 integration, risk assessment for supplied product, risk control verification
7.1
§820.10
14:00
Design controls (if supplier performs design)
Design inputs, outputs, verification, validation, transfer, changes
7.3
§820.30
15:00
Training and competence
Training records, competence assessment, awareness of regulatory requirements
6.2
§820.25
16:00
Day 1 wrap-up
Summarize findings, identify Day 2 focus areas
—
—
Day 2: Production, Purchasing, and Corrective Actions
Time
Agenda Item
Checklist Focus
ISO 13485 Reference
09:00
Production process controls
Process validation (IQ/OQ/PQ), work instructions, environmental controls, equipment maintenance
7.5.1, 7.5.2, 7.5.6
10:00
Traceability
Material traceability, lot/batch tracking, UDI labeling (if applicable)
7.5.9
10:45
Purchasing controls (supplier's own suppliers)
Supplier evaluation, sub-tier control, incoming inspection
7.4.1, 7.4.2, 7.4.3
11:30
Verification of purchased product
Incoming inspection, CoA/CoC review, testing records
7.4.3
13:00
Nonconforming product
NCR process, segregation, disposition, rework validation
8.3
13:45
Complaint handling
Complaint intake, evaluation, MDR/vigilance reporting, trend analysis
8.2.2
14:30
CAPA system
Root cause analysis, corrective actions, effectiveness checks, preventive actions
8.5.2, 8.5.3
15:15
Internal audit program
Audit schedule, auditor qualification, findings, CAPA linkage
8.2.4
16:00
Closing meeting
Present findings, nonconformities, observations, agreed timelines
—
Specialized Audit Checklists by Supplier Type
Outsourced Sterilization Supplier
#
Audit Item
Evidence to Review
Reference
1
Sterilization process validation (IQ/OQ/PQ)
Validation protocols and reports
ISO 11135 (EtO), ISO 11137 (radiation), ISO 17665 (steam)
2
Routine sterilization records
Process parameters, load configuration, cycle records
Applicable sterilization standard
3
Biological indicator or dosimeter management
BI lot release, dosimeter calibration
Applicable standard
4
Parametric release capability (if applicable)
Process parameters vs. product requirements
ISO 11137-1
5
Environmental monitoring
Facility cleanliness, microbial monitoring
ISO 13485 6.4
6
Product release procedures
Review and release criteria, quarantine procedures
ISO 13485 7.5.10
7
Change control for sterilization process
Notification of parameter or equipment changes
Quality agreement
8
Radiation source qualification (gamma/e-beam)
Source calibration, dose mapping
ISO 11137-2
Contract Testing Laboratory
#
Audit Item
Evidence to Review
Reference
1
ISO 17025 accreditation scope
Accreditation certificate, scope covers required test methods
ISO 17025
2
Test method validation/verification
Validation protocols, accuracy, precision, specificity data
ISO 13485 7.5.2
3
Equipment calibration and maintenance
Calibration certificates, maintenance logs
ISO 13485 7.6
4
Reference standard management
Reference material certificates, storage conditions
ISO 17025
5
Sample management and chain of custody
Sample receipt, identification, storage, disposal
ISO 17025
6
Data integrity and electronic records
21 CFR Part 11 compliance (if US market), audit trails
21 CFR Part 11
7
Proficiency testing results
Inter-laboratory comparison reports
ISO 17025
8
Subcontracted testing control
Qualification of sub-contracted labs
ISO 17025, ISO 13485 7.4
Software Development Supplier (SaMD / Embedded Software)
#
Audit Item
Evidence to Review
Reference
1
IEC 62304 compliance
Software lifecycle documentation, software safety classification
IEC 62304
2
Software development planning
Software development plan, milestones, deliverables
IEC 62304 Clause 5
3
Software requirements specification
SRS completeness, traceability to system requirements
IEC 62304 Clause 5.2
4
Software architecture and design
Architecture documents, design descriptions, unit interfaces
IEC 62304 Clause 5.3
5
SOUP (Software of Unknown Provenance) management
SOUP list, risk assessment, anomaly tracking
IEC 62304 Clause 7.1
6
Verification and validation
Test plans, test results, code reviews, integration testing
IEC 62304 Clause 5.7, 5.8
7
Configuration management
Version control, build records, release procedures
IEC 62304 Clause 8
8
Problem resolution
Defect tracking, root cause analysis, resolution verification
IEC 62304 Clause 9
9
Cybersecurity practices
Vulnerability management, SBOM, secure development lifecycle
IEC 81001-5-1, FDA cybersecurity guidance
10
AI/ML model management (if applicable)
Training data documentation, model validation, bias assessment
FDA AI/ML guidance, PCCP if applicable
Post-Audit Actions and CAPA Follow-Up
Grade
Definition
Response Timeline
Evidence Required
Major
Systemic failure or direct impact on device safety/effectiveness
30 days: corrective action plan; 90 days: implementation evidence
Root cause analysis, corrective actions, effectiveness verification
Minor
Isolated noncompliance not directly impacting safety
60 days: corrective action plan; 120 days: implementation evidence
Corrective action description, implementation evidence
Observation
Area for improvement, not a noncompliance
Next audit: status update
Improvement action description
CAPA Follow-Up Template
NC #
Description
Grade
Root Cause
Corrective Action
Due Date
Status
Effectiveness Check
NC-001
No evidence of incoming inspection for Component X
Major
Procedure exists but not followed for this component
Retrain personnel; add incoming inspection checkpoint in ERP
YYYY-MM-DD
Open
Verify at next audit
NC-002
Calibration overdue for test equipment #42
Minor
Missed calibration schedule due to personnel change
Calibrate immediately; update calibration schedule owner
YYYY-MM-DD
Closed
Confirmed calibrated
Ongoing Monitoring Checklist
#
Monitoring Activity
Frequency
Responsible
Evidence
1
Review supplier quality scorecard (on-time delivery, reject rate, CAPA closure rate)
Quarterly
Supplier Quality
Scorecard report
2
Review CoA/CoC for incoming lots
Per receipt
Quality Control
Incoming inspection records
3
Monitor regulatory actions against supplier (FDA WL, import alerts)
Monthly
Regulatory Affairs
Search results log
4
Review supplier's ISO 13485 surveillance/re-certification results
Per supplier's audit cycle
Supplier Quality
Audit reports
5
Track open CAPAs from supplier audits
Monthly
Supplier Quality
CAPA log
6
Evaluate supplier performance at management review
Annually
QA Manager
Management review minutes
7
Re-assess supplier risk tier based on performance data
Annually
Supplier Quality
Updated risk assessment
8
Review and update quality agreement
Annually or upon change
Regulatory Affairs / Supplier Quality
Signed updated agreement
Recommended Reading
Clinical Evaluation Report Template: EU MDR CER Structure, Tables, and Evidence Traceability
Clinical Evidence EU MDR / IVDR 2026-04-30 · 18 min read
FDA QMSR-Specific Considerations
Under QMSR (effective February 2, 2026), several changes affect supplier audit programs:
Change
Impact on Supplier Audit Program
Action Required
ISO 13485 incorporated by reference
Supplier controls must now align with ISO 13485 Clause 7.4 terminology and structure
Map existing QSR procedures to ISO 13485; update terminology
FDA can review supplier audit records
All supplier audit reports and CAPA records are now inspectable
Ensure documentation is complete, organized, and accessible
Risk-based approach formalized
Level of supplier control must be documented and proportionate to risk
Document risk classification rationale for every supplier
Management review must address supplier performance
Supplier quality data feeds into management review
Add supplier performance to management review agenda
CAPA now aligned with ISO 13485
Corrective and preventive actions separated; effectiveness checks required
Update CAPA procedures; verify supplier CAPA effectiveness
Key Takeaways
Classify every supplier into risk tiers (A through D) using documented criteria — the classification drives audit frequency, quality agreement requirements, and verification intensity
Under FDA QMSR, supplier audit records are now inspectable — treat every audit as if the FDA will read it
Customize on-site audit checklists by supplier type: sterilization, testing, and software suppliers each require specialized focus areas
Quality agreements for Tier A critical suppliers must cover scope, specifications, change control, right to audit, complaint notification, traceability, and regulatory inspection support
Close the loop: every audit finding requires documented root cause analysis, corrective action, and effectiveness verification tracked to completion
Monitor supplier performance continuously through scorecards, not just during periodic audits — quarterly reviews catch problems before they become nonconformities
Update risk classifications annually based on performance data, regulatory actions, and business changes — a supplier's tier can change over time